Stratasys, a provider of polymer 3D printing solutions, has expanded its partnership with Ricoh USA on a clinical study to assess the use of 3D-printed models for preoperative planning in orthopedic oncology. The two companies initially partnered in December 2023 to facilitate 3D printing of anatomical models for healthcare applications.
The study aims to investigate whether 3D-printed models can enhance preoperative planning and tumor excision compared to the traditional approach that relies solely on CT or MRI imaging. It will assess whether the models can lower blood loss, reduce procedural risks, and shorten operation times.
The study is expected to last 12 months and involve up to 150 participants from notable sites such as Ohio State University Wexner Medical Center and Corewell Health.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.